Agios Pharmaceuticals logo

AGIO Agios Pharmaceuticals

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Healthcare Biotechnology SIC: Unknown CIK: 1439222 

Login to follow AGIO

Transaction DateRecipientSharesTypePriceValue
Jodie Insights Rating